Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics

Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation ...

New Study Highlights the Role of Physical Color Calibration in Enhancing Digital Pathology Diagnostics by AI

A new international study, supported by PathQA, has shown that physical color calibration can solve...

Transforming Cancer Detection: Deep Bio’s AI Research Featured at USCAP Annual Meeting

Deep Bio, a leader in AI-driven cancer diagnostics, is excited to announce its participation in the ...

Novel AI Framework Sidesteps Gleason Grading to Predict Prostate Cancer Outcomes

Research from Lund University in Sweden showed that a new AI framework achieved high accuracy in pre...

New AI-Powered Digital Pathology System Could Speed Up TP53 Testing in Leukemia

For pathologists managing acute myeloid leukemia (AML), evaluating TP53 status often means choosing ...

Top 10 Great Things You’re Doing (and Should Be Doing) for Your Pathology & Oncology Software

The pathology and oncology fields are rapidly evolving, presenting exciting opportunities for softwa...